Cargando…

Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1

Longhu Rendan (LHRD), a Chinese traditional compound medicine, has a remarkable treatment effect on motion sickness for about half a century. However, the role of LHRD in atherosclerosis treatment is still unclear. In this study, LHRD treatment significantly diminished total cholesterol (TC), trigly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Sishan, Wu, Teng, Li, Ning, Zhang, Lingyi, Song, Jun, Xu, Yunzheng, Wang, Shumei, Ding, Liqin, Jin, Jiahua, Liu, Ying, Lan, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196979/ https://www.ncbi.nlm.nih.gov/pubmed/30402125 http://dx.doi.org/10.1155/2018/4812639

Ejemplares similares

Investigation of phytoplankton community structure and formation mechanism: a case study of Lake Longhu in Jinjiang
por: Jiang, Yongcan, et al.
Publicado: (2023)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
por: Kattoor, Ajoe John, et al.
Publicado: (2019)

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset
por: Di Rienzo, Carmine, et al.
Publicado: (2013)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
por: Ji, Wenyan, et al.
Publicado: (2020)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

The Traditional Chinese Medicine Hua Tuo Zai Zao Wan Alleviates Atherosclerosis by Deactivation of Inflammatory Macrophages
por: Yu, Zhihua, et al.
Publicado: (2022)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis
por: Ren, Yan, et al.
Publicado: (2017)

Effect assessment of laparoscopy in combination with traditional Chinese medicine decoction in the treatment of endometriosis: A protocol for systematic review and meta-analysis
por: Peng, Jiahua, et al.
Publicado: (2021)

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies
por: Rizzacasa, Barbara, et al.
Publicado: (2017)

Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways
por: Meng, Tianwei, et al.
Publicado: (2022)

Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo
por: Yin, Ya-Ling, et al.
Publicado: (2017)

MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo
por: Liu, Mingxin, et al.
Publicado: (2017)

Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis
por: Li, Wei, et al.
Publicado: (2020)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Neurogenic dysphagia in traditional Chinese medicine
por: Liu, Jia, et al.
Publicado: (2020)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1
por: Ding, Jiaxing, et al.
Publicado: (2022)

Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine
por: Liu, Guoqing, et al.
Publicado: (2023)

Cyclin G2 promotes the formation of smooth muscle cells derived foam cells in atherosclerosis via PP2A/NF-κB/LOX-1 pathway
por: Zhang, Di, et al.
Publicado: (2021)

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
por: Saatci, Ozge, et al.
Publicado: (2020)

Exploring the mechanism of atherosclerosis and the intervention of traditional Chinese medicine combined with mesenchymal stem cells based on inflammatory targets
por: Sun, Shibiao, et al.
Publicado: (2023)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments
por: Shaw, Daniel, et al.
Publicado: (2020)

Identification of the LOX Gene Family in Peanut and Functional Characterization of AhLOX29 in Drought Tolerance
por: Mou, Yifei, et al.
Publicado: (2022)

Dominant diseases of Traditional Chinese Medicine (TCM)
por: Wang, Jianjian, et al.
Publicado: (2022)

Current Status of Standardization of Traditional Chinese Medicine in China
por: Wang, Juan, et al.
Publicado: (2016)

Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population
por: Liu, Xu, et al.
Publicado: (2014)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Zhao, Wenjie, et al.
Publicado: (2021)

Characterization of Genetic Diversity and Linkage Disequilibrium of ZmLOX4 and ZmLOX5 Loci in Maize
por: De La Fuente, Gerald N., et al.
Publicado: (2013)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022)

Regulatory effect of traditional Chinese medicine on gut microbiota in patients with atherosclerosis: A protocol for systematic review and meta-analysis
por: Huang, Langlang, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese patent medicine on carotid artery atherosclerosis in adults: A network meta-analysis protocol
por: Sun, Huiqing, et al.
Publicado: (2021)

Is Traditional Chinese Medicine “Mainstream” in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016
por: Shi, Xuefeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h721224bi9k4b9hpf73cknbf9i